Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) EBITDA Margin (2019 - 2025)

Volitionrx filings provide 8 years of EBITDA Margin readings, the most recent being 163775.29% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 14839230.0% to 163775.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 2036.24%, a 85793.0% increase, with the full-year FY2025 number at 1894.44%, up 80270.0% from a year prior.
  • EBITDA Margin hit 163775.29% in Q4 2025 for Volitionrx, up from 1000.67% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 163775.29% in Q4 2025 to a low of 61692.56% in Q4 2021.
  • Median EBITDA Margin over the past 5 years was 5013.92% (2023), compared with a mean of 2388.21%.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 190771026bps in 2021 and later skyrocketed 8378bps in 2025.
  • Volitionrx's EBITDA Margin stood at 61692.56% in 2021, then surged by 90bps to 6201.93% in 2022, then surged by 42bps to 3605.06% in 2023, then soared by 527bps to 15382.99% in 2024, then surged by 965bps to 163775.29% in 2025.
  • The last three reported values for EBITDA Margin were 163775.29% (Q4 2025), 1000.67% (Q3 2025), and 1694.19% (Q2 2025) per Business Quant data.